ATAI Life Sciences NV (ATAI)
1.84
-0.03
(-1.60%)
USD |
NASDAQ |
Apr 25, 16:00
1.88
+0.04
(+2.17%)
After-Hours: 20:00
ATAI Life Sciences Market Cap: 305.49M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 305.49M |
| April 24, 2024 | 310.47M |
| April 23, 2024 | 327.07M |
| April 22, 2024 | 310.47M |
| April 19, 2024 | 307.15M |
| April 18, 2024 | 317.11M |
| April 17, 2024 | 328.73M |
| April 16, 2024 | 356.96M |
| April 15, 2024 | 343.67M |
| April 12, 2024 | 381.86M |
| April 11, 2024 | 410.09M |
| April 10, 2024 | 403.44M |
| April 09, 2024 | 396.80M |
| April 08, 2024 | 431.67M |
| April 05, 2024 | 406.76M |
| April 04, 2024 | 416.73M |
| April 03, 2024 | 396.80M |
| April 02, 2024 | 310.47M |
| April 01, 2024 | 308.81M |
| March 28, 2024 | 327.07M |
| March 27, 2024 | 297.19M |
| March 26, 2024 | 287.23M |
| March 25, 2024 | 275.60M |
| March 22, 2024 | 270.62M |
| March 21, 2024 | 277.26M |
| Date | Value |
|---|---|
| March 20, 2024 | 282.24M |
| March 19, 2024 | 277.26M |
| March 18, 2024 | 277.26M |
| March 15, 2024 | 293.87M |
| March 14, 2024 | 278.92M |
| March 13, 2024 | 305.49M |
| March 12, 2024 | 317.11M |
| March 11, 2024 | 335.37M |
| March 08, 2024 | 348.66M |
| March 07, 2024 | 363.60M |
| March 06, 2024 | 330.39M |
| March 05, 2024 | 333.71M |
| March 04, 2024 | 347.00M |
| March 01, 2024 | 353.64M |
| February 29, 2024 | 322.09M |
| February 28, 2024 | 325.41M |
| February 27, 2024 | 332.05M |
| February 26, 2024 | 315.45M |
| February 23, 2024 | 303.83M |
| February 22, 2024 | 303.83M |
| February 21, 2024 | 312.13M |
| February 20, 2024 | 333.71M |
| February 16, 2024 | 305.49M |
| February 15, 2024 | 298.85M |
| February 14, 2024 | 293.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
172.65M
Minimum
Nov 30 2023
3.035B
Maximum
Jun 21 2021
799.64M
Average
496.80M
Median
Market Cap Benchmarks
| Affimed NV | 74.31M |
| InflaRx NV | 81.85M |
| MorphoSys AG | 2.727B |
| BioNTech SE | 20.61B |
| Immatics NV | 1.007B |
Market Cap Related Metrics
| PS Ratio | 962.64 |
| Price to Book Value | 1.257 |
| Price | 1.84 |
| Earnings Yield | -15.22% |